Family Medicine · Fairfax, VA
NPI
1144291097
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
10801 Main St, Suite 700
Fairfax, VA, 22030
Phone (703) 591-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$268K
3,985 services
Medicare patients, 2024
503
Average age 77
Drug cost, 2024
$2.3M
16,879 prescriptions
Company payments, 2025
$812
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael D Kim was code 99214 (office e&m - established), 1,452 times for 480 patients. In total Michael D Kim billed 3,985 services in 25 codes, and Medicare paid $268K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,452 | 480 | $98.10 | $142K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,049 | 444 | $14.55 | $15K |
| 99213 Office E&M - Established | Office | 469 | 258 | $67.66 | $32K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 275 | 275 | $149.44 | $41K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 248 | 248 | $22.27 | $5,523 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 112 | 112 | $21.30 | $2,385 |
| G0008 Administration of influenza virus vaccine | Office | 71 | 71 | $35.85 | $2,545 |
| 90662 Vaccine Product | Office | 71 | 71 | $81.82 | $5,809 |
| 93000 Electrocardiogram | Office | 66 | 63 | $12.08 | $797 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 34 | 31 | $190.42 | $6,474 |
| 99204 Office E&M - New | Office | 29 | 29 | $119.11 | $3,454 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 26 | 26 | $189.24 | $4,920 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 18 | 16 | $46.79 | $842 |
By year: 2022 $322K for 5,767 services; 2023 $263K for 3,257 services; 2024 $268K for 3,985 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael D Kim prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,677 prescriptions and refills. In total Michael D Kim wrote 16,879 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,677 | 4,859 | 543 | $11K |
| Amlodipine Besylate Generic | 1,370 | 3,860 | 403 | $7,145 |
| Rosuvastatin Calcium Generic | 835 | 2,453 | 263 | $9,422 |
| Metformin Hcl Generic | 676 | 1,921 | 205 | $3,661 |
| Losartan Potassium Generic | 658 | 1,862 | 193 | $5,332 |
| Simvastatin Generic | 393 | 1,113 | 114 | $2,404 |
| Tamsulosin Hcl Generic | 391 | 1,090 | 109 | $5,165 |
| Metoprolol Succinate Generic | 347 | 908 | 98 | $3,630 |
| Sertraline Hcl Generic | 334 | 632 | 81 | $1,725 |
| Alendronate Sodium Generic | 296 | 813 | 104 | $1,453 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 280 | 811 | 78 | $2,290 |
| Montelukast Sodium Generic | 260 | 651 | 83 | $2,799 |
| Levothyroxine Sodium Generic | 258 | 717 | 75 | $2,113 |
| Celecoxib Generic | 255 | 355 | 73 | $4,241 |
| Gabapentin Generic | 249 | 404 | 79 | $3,684 |
Brand drugs: 2,318 claims; generic drugs: 14,442 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael D Kim $812 ($812 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $131.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 6 | $131 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $126 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95.54 |
| Lilly USA, LLC LLY | 5 | $88.73 |
| Gilead Sciences, Inc. GILD | 4 | $88.22 |
| Amgen Inc. AMGN | 3 | $48.46 |
| Pfizer Inc. PFE | 2 | $47.04 |
| Exact Sciences Corporation EXAS | 2 | $35.66 |
| Scilex Pharmaceuticals Inc. | 1 | $24.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.